EIF5A and metabolic dysfunction-associated steatohepatitis: The fact that eIF5A activity improves the NASH score before tumor onset and worsens the prognosis after HCC onset is not surprising because it depends on the cellular context, highly proliferative in HCC, versus requiring fatty acid oxidation in preventing NAFLD evolution.